Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BD Combinations of oral blood glucose lowering drugs
A10BD24 Sitagliptin and ertugliflozin
D11066 Ertugliflozin and sitagliptin <US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Combinations
Ertugliflozin/ Sitagliptin
D11066 Ertugliflozin and sitagliptin
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03035 Combination of DPP-4 inhibitor and SGLT2 inhibitor
D11066 Ertugliflozin and sitagliptin
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03188 UGT1A9 substrate
D11066 Ertugliflozin and sitagliptin
DG03190 UGT2B7 substrate
D11066 Ertugliflozin and sitagliptin
Drug classes [BR:br08332]
Antidiabetic agent
DG02044 Hypoglycemic agent
D11066 Ertugliflozin and sitagliptin
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11066
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11066